CellCarta Competitors and Similar CompaniesClear all
CellCarta's competitors and similar companies include SOPHiA GENETICS, DNAnexus and Geneseeq.
 CellCarta CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory. |  SOPHiA GENETICS SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine. |  Geneseeq Geneseeq Technology (also known as 世和基因, Geneseeq Tech) is a biotech company that is focused on the research and clinical translation of next-generation sequencing (NGS) in the field of personalized medicine. | ||
Founding Date | Founding Date 2001 | Founding Date 2011 | Founding Date 2009 | Founding Date 2008 |
Type | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Antwerpen, BE HQ Berchem, BE Naperville, US | Locations Rolle, CH HQ Bidart, FR Boston, US | Locations Mountain View, US HQ | Locations Toronto, CA HQ |
Employees | Employees 4 | Employees 423 | Employees 2822% increase | Employees 338% decrease |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 100m (about 6 years ago) | Latest funding round $ 114.4m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 245.8m | Total funding raised $ 272.6m | Total funding raised $ 135.6m |
For sources of this data, please see the company profile
View Company Profiles
SOPHiA GENETICS
HQ
Rolle, CH
Employees
423
SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine.
View company
DNAnexus
HQ
Mountain View, US
Employees
282↑ 2% increase
DNAnexus is a company that develops a cloud computing and bioinformatics platform.
View companyGeneseeq
HQ
Toronto, CA
Employees
33↓ 8% decrease
Geneseeq Technology (also known as 世和基因, Geneseeq Tech) is a biotech company that is focused on the research and clinical translation of next-generation sequencing (NGS) in the field of personalized medicine.
View company